Last updated: August 30, 2024
Sponsor: Centro Cardiologico Monzino
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Inflammation
Insomnia
Narcolepsy
Treatment
Tests for markers of inflammation and activated hemostasis
Clinical Study ID
NCT05775731
CCM 1788
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Hospital worker who either works in shifts including night shifts, or only duringthe day
Exclusion
Exclusion Criteria:
Known sleep disorder diagnosed by polysomnography and/or nocturnal saturation study
Sleep apnea-hypopnea syndrome in C-PAP (Continuous Positive Airway Pressure)treatment
Chronic treatment with sleep-inducers
Chronic heart failure class NYHA III and IV
Ischemic heart disease
Venous thromboembolism
Chronic anticoagulant and/or anti-platelet therapy
Study Design
Total Participants: 150
Treatment Group(s): 1
Primary Treatment: Tests for markers of inflammation and activated hemostasis
Phase:
Study Start date:
September 27, 2022
Estimated Completion Date:
December 30, 2024
Study Description
Connect with a study center
Centro Cardiologico Monzino
Milan, 20138
ItalySite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.